Replication licensing promotes cyclin D1 expression and G1 progression in untransformed human cells

Cell Cycle

Volumn 8, Issue 1, 2009, Pages 125-136

  Liu, Peijun ^a   Slater, Damien M ^a   Lenburg, Marc ^a   Nevis, Kathleen ^b   Cook, Jeanette Gowen ^b   Vaziri, Cyrus ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclin D1; DNA replication; G1 progression; Licensing; Pre RC

Indexed keywords

CELL CYCLE PROTEIN 6; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; MINICHROMOSOME MAINTENANCE PROTEIN 7; PROTEIN E7; RETINOBLASTOMA PROTEIN; RNA POLYMERASE II; CCND1 PROTEIN, HUMAN; CDC6 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DNA BINDING PROTEIN; MCM7 PROTEIN, HUMAN; NUCLEAR PROTEIN;

ARTICLE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; BIOLOGICAL MODEL; CELL CULTURE; CYTOLOGY; DERMIS; DOWN REGULATION; FIBROBLAST; METABOLISM;

HUMAN PAPILLOMAVIRUS;

CELL CYCLE PROTEINS; CELLS, CULTURED; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DERMIS; DNA DAMAGE; DNA REPLICATION; DNA-BINDING PROTEINS; DOWN-REGULATION; FIBROBLASTS; G1 PHASE; HUMANS; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; PAPILLOMAVIRUS E7 PROTEINS; RETINOBLASTOMA PROTEIN; S PHASE;

EID: 60749084686     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.1.7528     Document Type: Article

References (53)

1. Bell SP, Dutta A. DNA replication in eukaryotic cells. Annu Rev Biochem 2002; 71:333-74.
2. Takeda DY, Dutta A. DNA replication and progression through S phase. Oncogene 2005; 24:2827-43.
3. Takahashi TS, Wigley DB, Walter JC. Pumps, paradoxes and ploughshares: mechanism of the MCM2-7 DNA helicase. Trends Biochem Sci 2005; 30:437-44.
4. 1/S-regulatory genes. Mol Cell Biol 1995; 15:4215-24.
5. Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams RS, et al. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev 1998; 12:2120-30.
6. Frolov MV, Dyson NJ. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J Cell Sci 2004; 117:2173-81.
7. 1. Cell 1999; 98:859-69.
8. Lundberg AS, Weinberg RA. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 1998; 18:753-61.
9. Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, Tamai K, et al. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. Embo J 1996; 15:7060-9.
10. Counter CM, Hahn WC, Wei W, Caddle SD, Beijersbergen RL, Lansdorp PM, et al. Dissociation among in vitro telomerase activity, telomere maintenance and cellular immortalization. Proc Natl Acad Sci USA 1998; 95:14723-8.
11. Mailand N, Diffley JF. CDKs promote DNA replication origin licensing in human cells by protecting Cdc6 from APC/C-dependent proteolysis. Cell 2005; 122:915-26.
12. Shima N, Alcaraz A, Liachko I, Buske TR, Andrews CA, Munroe RJ, et al. A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice. Nat Genet 2007; 39:93-8.
13. Shreeram S, Sparks A, Lane DP, Blow JJ. Cell type-specific responses of human cells to inhibition of replication licensing. Oncogene 2002; 21:6624-32.
14. Machida YJ, Teer JK, Dutta A. Acute reduction of an origin recognition complex (ORC) subunit in human cells reveals a requirement of ORC for Cdk2 activation. J Biol Chem 2005; 280:27624-30.
15. Weinert T, Lydall D. Cell cycle checkpoints, genetic instability and cancer. Seminars in cancer biology 1993; 4:129-40.
16. 1 cell cycle arrest in response to DNA damage. Cell 2000; 102:55-66.
17. Chehab NH, Malikzay A, Appel M, Halazonetis TD. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev 2000; 14:278-88.
18. Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 2000; 287:1824-7.
19. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73:39-85.
20. Dziak R, Leishman D, Radovic M, Tye BK, Yankulov K. Evidence for a role of MCM (mini-chromosome maintenance)5 in transcriptional repression of sub-telomeric and Ty-proximal genes in Saccharomyces cerevisiae. J Biol Chem 2003; 278:27372-81.
21. Fitch MJ, Donato JJ, Tye BK. Mcm7, a subunit of the presumptive MCM helicase, modulates its own expression in conjunction with Mcm1. J Biol Chem 2003; 278:25408-16.
22. Cook JG, Park CH, Burke TW, Leone G, DeGregori J, Engel A, et al. Analysis of Cdc6 function in the assembly of mammalian prereplication complexes. Proc Natl Acad Sci USA 2002; 99:1347-52.
23. Delmolino LM, Saha P, Dutta A. Multiple mechanisms regulate subcellular localization of human CDC6. J Biol Chem 2001; 276:26947-54.
24. DaFonseca CJ, Shu F, Zhang JJ. Identification of two residues in MCM5 critical for the assembly of MCM complexes and Stat1-mediated transcription activation in response to IFNgamma. Proc Natl Acad Sci USA 2001; 98:3034-9.
25. Zhang JJ, Zhao Y, Chait BT, Lathem WW, Ritzi M, Knippers R, et al. Ser727-dependent recruitment of MCM5 by Stat1alpha in IFNgamma-induced transcriptional activation. Embo J 1998; 17:6963-71.
26. Snyder M, He W, Zhang JJ. The DNA replication factor MCM5 is essential for Stat1-mediated transcriptional activation. Proc Natl Acad Sci USA 2005; 102:14539-44.
27. Holland L, Gauthier L, Bell-Rogers P, Yankulov K. Distinct parts of minichromosome maintenance protein 2 associate with histone H3/H4 and RNA polymerase II holoenzyme. Eur J Biochem 2002; 269:5192-202.
28. Yankulov K, Todorov I, Romanowski P, Licatalosi D, Cilli K, McCracken S, et al. MCM proteins are associated with RNA polymerase II holoenzyme. Mol Cell Biol 1999; 19:6154-63.
29. Sawyer SL, Cheng IH, Chai W, Tye BK. Mcm10 and Cdc45 cooperate in origin activation in Saccharomyces cerevisiae. J Mol Biol 2004; 340:195-202.
30. Gambus A, Jones RC, Sanchez-Diaz A, Kanemaki M, van Deursen F, Edmondson RD, et al. GINS maintains association of Cdc45 with MCM in replisome progression complexes at eukaryotic DNA replication forks. Nat Cell Biol 2006; 8:358-66.
31. Auth T, Kunkel E, Grummt F. Interaction between HP1alpha and replication proteins in mammalian cells. Exp Cell Res 2006; 312:3349-59.
32. Laribee RN, Fuchs SM, Strahl BD. H2B ubiquitylation in transcriptional control: a FACT-finding mission. Genes Dev 2007; 21:737-43.
33. Gauthier L, Dziak R, Kramer DJ, Leishman D, Song X, Ho J, et al. The role of the carboxy-terminal domain of RNA polymerase II in regulating origins of DNA replication in Saccharomyces cerevisiae. Genetics 2002; 162:1117-29.
34. Weinreich M, Liang C, Chen HH, Stillman B. Binding of cyclin-dependent kinases to ORC and Cdc6p regulates the chromosome replication cycle. Proc Natl Acad Sci USA 2001; 98:11211-7.
35. Furstenthal L, Kaiser BK, Swanson C, Jackson PK. Cyclin E uses Cdc6 as a chromatin-associated receptor required for DNA replication. J Cell Biol 2001; 152:1267-78.
36. Mimura S, Seki T, Tanaka S, Diffley JF. Phosphorylation-dependent binding of mitotic cyclins to Cdc6 contributes to DNA replication control. Nature 2004; 431:1118-23.
37. Jallepalli PV, Brown GW, Muzi-Falconi M, Tien D, Kelly TJ. Regulation of the replication initiator protein p65cdc18 by CDK phosphorylation. Genes Dev 1997; 11:2767-79.
38. Honey S, Futcher B. Roles of the CDK phosphorylation sites of yeast Cdc6 in chromatin binding and rereplication. Mol Biol Cell 2007; 18:1324-36.
39. Duursma AM, Agami R. CDK-dependent stabilization of Cdc6: linking growth and stress signals to activation of DNA replication. Cell Cycle 2005; 4:1725-8.
40. 1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts. Curr Biol 1998; 8:65-8.
41. Abbas T, Jha S, Sherman NE, Dutta A. Autocatalytic phosphorylation of CDK2 at the activating Thr160. Cell Cycle 2007; 6:843-52.
42. Teer JK, Machida YJ, Labit H, Novac O, Hyrien O, Marheineke K, et al. Proliferating human cells hypomorphic for origin recognition complex 2 and pre-replicative complex formation have a defect in p53 activation and Cdk2 kinase activation. J Biol Chem 2006; 281:6253-60.
43. 1-phase and are required to establish, but not maintain, the S-phase checkpoint. Mol Biol Cell 2001; 12:3658-67.
44. 1 is important for the onset of S phase and for preventing a 'reductional' anaphase in the budding yeast Saccharomyces cerevisiae. Embo J 1995; 14:3788-99.
45. Shirahige K, Hori Y, Shiraishi K, Yamashita M, Takahashi K, Obuse C, et al. Regulation of DNA-replication origins during cell cycle progression. Nature 1998; 395:618-21.
46. Weinberger M, Trabold PA, Lu M, Sharma K, Huberman JA, Burhans WC. Induction by adozelesin and hydroxyurea of origin recognition complex-dependent DNA damage and DNA replication checkpoints in Saccharomyces cerevisiae. J Biol Chem 1999; 274:35975-84.
47. Shimada K, Pasero P, Gasser SM. ORC and the intra-S-phase checkpoint: a threshold regulates Rad53p activation in S phase. Genes Dev 2002; 16:3236-52.
48. Dillin A, Rine J. Roles for ORC in M phase and S phase. Science 1998; 279:1733-7.
49. Takai H, Naka K, Okada Y, Watanabe M, Harada N, Saito S, et al. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. Embo J 2002; 21:5195-205.
50. Weinberger M, Ramachandran L, Feng L, Sharma K, Sun X, Marchetti M, et al. Apoptosis in budding yeast caused by defects in initiation of DNA replication. J Cell Sci 2005; 118:3543-53.
51. Pruitt SC, Bailey KJ, Freeland A. Reduced Mcm2 Expression Results in Severe Stem/ Progenitor Cell Deficiency and Cancer. Stem Cells 2007.
52. Jagadeesh S, Banerjee PP. Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1. Biochem Biophys Res Commun 2006; 347:774-80.
53. Liu P, Barkley LR, Day T, Bi X, Slater DM, Alexandrow MG, et al. The Chk1-mediated S-phase checkpoint targets initiation factor Cdc45 via a Cdc25a/Cdk2-independent mechanism. J Biol Chem 2006.